3 studies found for:    18413705 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Pexacerfont for Stress-induced Food Craving
Conditions: Daily Oral Pexacerfont for 28 Days (300 mg/Day Loading Dose for 7 Days, Followed;   Placebo
Intervention: Drug: Pexacerfont
2 Withdrawn Pexacerfont to Reduce Stress-induced Tobacco Craving
Condition: Nicotine Dependence
Intervention:
3 Terminated Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: CP-316,311;   Drug: Placebo;   Drug: Sertraline

Indicates status has not been verified in more than two years